Subscribe To Our Free Newsletter |
Dr Reddy’s continues to see selling, down over 5%
Shares of Dr Reddy’s Lab continued to face selling pressure for a third straight session today on receiving a warning letter from the US drug regulator over quality issues at its two API manufactu...